These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11846636

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Safety evaluation of recombinant human interleukin-4. II. Clinical studies.
    Leach MW, Rybak ME, Rosenblum IY.
    Clin Immunol Immunopathol; 1997 Apr; 83(1):12-4. PubMed ID: 9073527
    [Abstract] [Full Text] [Related]

  • 23. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 24. Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety.
    Ryan PC, Sleeman MA, Rebelatto M, Wang B, Lu H, Chen X, Wu CY, Hinrichs MJ, Roskos L, Towers H, McKeever K, Dixit R.
    Toxicol Appl Pharmacol; 2014 Sep 01; 279(2):230-9. PubMed ID: 24937321
    [Abstract] [Full Text] [Related]

  • 25. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
    Gad SC, Sullivan DW, Crapo JD, Spainhour CB.
    Int J Toxicol; 2013 Jul 01; 32(4):274-87. PubMed ID: 23704100
    [Abstract] [Full Text] [Related]

  • 26. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.
    Ferdinandi ES, Brazeau P, High K, Procter B, Fennell S, Dubreuil P.
    Basic Clin Pharmacol Toxicol; 2007 Jan 01; 100(1):49-58. PubMed ID: 17214611
    [Abstract] [Full Text] [Related]

  • 27. Nedocromil sodium preclinical safety evaluation studies: a preliminary report.
    Clark B, Clarke AJ, Bamford DG, Greenwood B.
    Eur J Respir Dis Suppl; 1986 Jan 01; 147():248-51. PubMed ID: 3021495
    [Abstract] [Full Text] [Related]

  • 28. Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cells.
    Lebrec H, Narayanan P, Nims R.
    J Appl Toxicol; 2010 Jul 01; 30(5):387-96. PubMed ID: 20589744
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluations of organ system development in juvenile toxicology testing.
    Robinson K.
    Reprod Toxicol; 2008 Sep 01; 26(1):51-3. PubMed ID: 18595655
    [Abstract] [Full Text] [Related]

  • 38. Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems.
    Dixit R, Coats S.
    IDrugs; 2009 Feb 01; 12(2):103-8. PubMed ID: 19204884
    [Abstract] [Full Text] [Related]

  • 39. Preclinical safety evaluation of Gd-EOB-DTPA (Primovist).
    Döhr O, Hofmeister R, Treher M, Schweinfurth H.
    Invest Radiol; 2007 Dec 01; 42(12):830-41. PubMed ID: 18007155
    [Abstract] [Full Text] [Related]

  • 40. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics.
    Int J Toxicol; 2005 Dec 01; 24 Suppl 2():21-50. PubMed ID: 16154914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.